Since the predictions made in this report are for peptides with a large coverage of MHC-II alleles in the human population, experimental validation will prove of great relevance to better understand the role of TERT CD4 T cell immunity in immune surveillance and for immunotherapy of cancer. The gene discussed is CD4; the disease is cancer.